- Home
- AMKR vs CORT Comparison
AMKR vs CORT Comparison
Compare AMKR & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMKR
- CORT
- Stock Information
- Founded
- AMKR 1968
- CORT 1998
- Country
- AMKR United States
- CORT United States
- Employees
- AMKR N/A
- CORT N/A
- Industry
- AMKR Semiconductors
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- AMKR Technology
- CORT Health Care
- Exchange
- AMKR Nasdaq
- CORT Nasdaq
- Market Cap
- AMKR 6.1B
- CORT 7.1B
- IPO Year
- AMKR 1998
- CORT N/A
- Fundamental
- Price
- AMKR $16.40
- CORT $69.27
- Analyst Decision
- AMKR Buy
- CORT Strong Buy
- Analyst Count
- AMKR 7
- CORT 4
- Target Price
- AMKR $31.33
- CORT $143.25
- AVG Volume (30 Days)
- AMKR 2.9M
- CORT 2.5M
- Earning Date
- AMKR 04-28-2025
- CORT 05-05-2025
- Dividend Yield
- AMKR 4.41%
- CORT N/A
- EPS Growth
- AMKR N/A
- CORT 30.85
- EPS
- AMKR 1.43
- CORT 1.23
- Revenue
- AMKR $6,317,692,000.00
- CORT $675,040,000.00
- Revenue This Year
- AMKR $1.46
- CORT $36.81
- Revenue Next Year
- AMKR $8.41
- CORT $32.00
- P/E Ratio
- AMKR $11.55
- CORT $56.50
- Revenue Growth
- AMKR N/A
- CORT 39.94
- 52 Week Low
- AMKR $14.03
- CORT $22.00
- 52 Week High
- AMKR $44.86
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- AMKR 42.99
- CORT 51.77
- Support Level
- AMKR $15.24
- CORT $61.75
- Resistance Level
- AMKR $17.49
- CORT $71.15
- Average True Range (ATR)
- AMKR 1.28
- CORT 5.30
- MACD
- AMKR 0.12
- CORT -1.18
- Stochastic Oscillator
- AMKR 60.00
- CORT 35.45
About AMKR Amkor Technology Inc.
Amkor Technology Inc is a provider of outsourced semiconductor packaging and test services to integrated device manufacturers, fabless semiconductor companies, and contract foundries. The firm's products are organized into two categories namely advanced products that include flip chip, fine pitch bumping, wafer-level processing, advanced SiPs, power modules, and others, and Mainstream products that includes wirebond packaging and testing. The company derives maximum revenue from the advanced products category. The company derives majority of its revenue from Foreign states.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.